The CDC estimates that over 73,000 cases of E. coli O157:H7 infections occur annually in the US, but the pathogenesis of E. coli O157:H7 is poorly understood. The first step in gastro-intestinal disease is colonization, yet despite extensive research next to nothing is known about this process. To colonize the intestinal tract, E. coli O157:H7 must survive the hostile acidic pH of the gastric contents, pass through the small intestine, adhere to the colonic intestinal epithelium, adapt to the colonic environment, and acquire essential nutrients for growth. The same is true for the 400-500 commensal species that inhabit the mammalian large intestine and again, next to nothing is known about this process. For the last few years, we have used colonization by commensal E. coli strains as a model and are beginning to understand the process better. Mucus provides the nutrients necessary for commensal E. coli strains to colonize. Our results substantiate the essential role of mucus-derived sugar acids-hexonic and neuronic acids-for intestinal colonization by E. coli and stand in contrast to widely held, yet unchallenged assumption that glucose is the major carbon source available to microbial invaders- but there is essentially no free glucose in the colon. Our improved understanding of colonization came as we began to use functional genomics tools for examining E. coli metabolism during in vitro growth and intestinal colonization by commensal strains to include a pathogen. We will develop functional genomic tools to understand the in situ physiology of E. coli O157:H7, and thus illuminate the process by which intestinal pathogens first colonize a host.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
1P20RR015564-01
Application #
6399263
Study Section
Special Emphasis Panel (ZRR1)
Project Start
2000-09-15
Project End
2005-08-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2000
Total Cost
Indirect Cost
Name
University of Oklahoma Health Sciences Center
Department
Type
DUNS #
937727907
City
Oklahoma City
State
OK
Country
United States
Zip Code
73117
Kolb, Aaron W; Schmidt, Timothy R; Dyer, David W et al. (2011) Sequence variation in the herpes simplex virus U(S)1 ocular virulence determinant. Invest Ophthalmol Vis Sci 52:4630-8
Boileau, Mélanie J; Clinkenbeard, Kenneth D; Iandolo, John J (2011) Assessment of Bdellovibrio bacteriovorus 109J killing of Moraxella bovis in an in vitro model of infectious bovine keratoconjunctivitis. Can J Vet Res 75:285-91
Jackson, Lydgia A; Ducey, Thomas F; Day, Michael W et al. (2010) Transcriptional and functional analysis of the Neisseria gonorrhoeae Fur regulon. J Bacteriol 192:77-85
LaChapelle, Stephanie; Tweten, Rodney K; Hotze, Eileen M (2009) Intermedilysin-receptor interactions during assembly of the pore complex: assembly intermediates increase host cell susceptibility to complement-mediated lysis. J Biol Chem 284:12719-26
Robinson, Christopher M; Shariati, Fatemeh; Zaitshik, Jeremy et al. (2009) Human adenovirus type 19: genomic and bioinformatics analysis of a keratoconjunctivitis isolate. Virus Res 139:122-6
Lang, Mark L (2009) How do natural killer T cells help B cells? Expert Rev Vaccines 8:1109-21
Ishiga, Yasuhiro; Uppalapati, Srinivasa Rao; Ishiga, Takako et al. (2009) The phytotoxin coronatine induces light-dependent reactive oxygen species in tomato seedlings. New Phytol 181:147-60
Folster, Jason P; Johnson, Paul J T; Jackson, Lydgia et al. (2009) MtrR modulates rpoH expression and levels of antimicrobial resistance in Neisseria gonorrhoeae. J Bacteriol 191:287-97
Uppalapati, Srinivasa Rao; Ishiga, Yasuhiro; Wangdi, Tamding et al. (2008) Pathogenicity of Pseudomonas syringae pv. tomato on tomato seedlings: phenotypic and gene expression analyses of the virulence function of coronatine. Mol Plant Microbe Interact 21:383-95
Devera, T Scott; Shah, Hemangi B; Lang, Gillian A et al. (2008) Glycolipid-activated NKT cells support the induction of persistent plasma cell responses and antibody titers. Eur J Immunol 38:1001-11

Showing the most recent 10 out of 52 publications